Loddenkemper R - Search Results

1

Economic burden of bronchiectasis in Germany.

Diel R, Chalmers JD, Rabe KF, Nienhaus A, Loddenkemper R, Ringshausen FC. Diel R, et al. Among authors: loddenkemper r. Eur Respir J. 2019 Feb 28;53(2):1802033. doi: 10.1183/13993003.02033-2018. Print 2019 Feb. Eur Respir J. 2019. PMID: 30523162 Free article.

2

Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany.

Diel R, Schaberg T, Loddenkemper R, Welte T, Nienhaus A. Diel R, et al. Among authors: loddenkemper r. Respir Med. 2009 Dec;103(12):1838-53. doi: 10.1016/j.rmed.2009.07.008. Epub 2009 Aug 13. Respir Med. 2009. PMID: 19682884 Free article.

3

Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.

Diel R, Loddenkemper R, Nienhaus A. Diel R, et al. Among authors: loddenkemper r. Chest. 2012 Jul;142(1):63-75. doi: 10.1378/chest.11-3157. Chest. 2012. PMID: 22490872 Review.

4

Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.

Diel R, Loddenkemper R, Zellweger JP, Sotgiu G, D'Ambrosio L, Centis R, van der Werf MJ, Dara M, Detjen A, Gondrie P, Reichman L, Blasi F, Migliori GB; European Forum for TB Innovation. Diel R, et al. Among authors: loddenkemper r. Eur Respir J. 2013 Sep;42(3):785-801. doi: 10.1183/09031936.00205512. Epub 2013 Feb 8. Eur Respir J. 2013. PMID: 23397299 Free article.

5

Consequences of tuberculosis among asylum seekers for health care workers in Germany.

Diel R, Loddenkemper R, Nienhaus A. Diel R, et al. Among authors: loddenkemper r. J Occup Med Toxicol. 2016 Feb 16;11:4. doi: 10.1186/s12995-016-0093-x. eCollection 2016. J Occup Med Toxicol. 2016. PMID: 26884805 Free PMC article.

6

Microbiologic Outcome of Interventions Against Mycobacterium avium Complex Pulmonary Disease: A Systematic Review.

Diel R, Nienhaus A, Ringshausen FC, Richter E, Welte T, Rabe KF, Loddenkemper R. Diel R, et al. Among authors: loddenkemper r. Chest. 2018 Apr;153(4):888-921. doi: 10.1016/j.chest.2018.01.024. Epub 2018 Feb 2. Chest. 2018. PMID: 29410162

7

Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update.

Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Diel R, et al. Among authors: loddenkemper r. Am J Respir Crit Care Med. 2011 Jan 1;183(1):88-95. doi: 10.1164/rccm.201006-0974OC. Epub 2010 Aug 27. Am J Respir Crit Care Med. 2011. PMID: 20802162

8

To repeat or not to repeat-that is the question!: Serial testing of health-care workers for TB infection.

Loddenkemper R, Diel R, Nienhaus A. Loddenkemper R, et al. Chest. 2012 Jul;142(1):10-11. doi: 10.1378/chest.12-0045. Chest. 2012. PMID: 22796831 No abstract available.

9

Cost-effectiveness of treating latent tuberculous infection: a step towards elimination?

Diel R, Loddenkemper R, Sotgiu G, Migliori GB. Diel R, et al. Among authors: loddenkemper r. Int J Tuberc Lung Dis. 2013 Dec;17(12):1515. doi: 10.5588/ijtld.13.0706. Int J Tuberc Lung Dis. 2013. PMID: 24200259 No abstract available.

10

Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.

Diel R, Nienhaus A, Loddenkemper R. Diel R, et al. Among authors: loddenkemper r. Chest. 2007 May;131(5):1424-34. doi: 10.1378/chest.06-2728. Chest. 2007. PMID: 17494792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page